H.P. Acthar® Gel — Proven Therapy for Treating MS Exacerbations

Healthcare Professionals

Healthcare Professionals

H.P. Acthar® Gel (repository corticotropin injection) is indicated for the treatment of acute exacerbations in patients with multiple sclerosis, for the diagnosis of adrenocortical function, and for several other uses.

Acthar Delivers Proven Relief of MS Exacerbations

  • No differences in efficacy shown between Acthar and IV steroids
    • Acthar effectively accelerates recovery from acute MS exacerbations and improves patients' disability scores[1][2][3][4]
    • In multiple head-to-head clinical studies, there were no demonstrated differences between the efficacy of IV steroids and ACTH[1][3][5]

Some Patients Need an Alternative to IV Steroids

  • Consider Acthar when your patients...
    • Have poor venous access
    • Express tolerability concerns with IV steroids
    • Report an inadequate response to IV steroids
    • Need the flexibility of a self-injection at home or work

Quote Image I had no idea there are other treatment options out there and thought IV steroids were the only way to treat my MS relapses.

- Patient treated for MS exacerbation with Acthar

References

  1. ^ Thompson AJ, Kennard C, Swash M, et al. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology. 1989;39:969-971.
  2. ^ H.P. Acthar® Gel (repository corticotropin injection), prescribing information, Questcor Pharmaceuticals, Inc.
  3. ^ Milanese C, La Mantia L, Salmaggi A, et al. Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Eur Neurol. 1989;29:10-14.
  4. ^ Rose AS, Kuzma JW, Kurtzke JF, et al. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs. placebo-final report. Neurology. 1970:20:1-59.
  5. ^ Barnes MP, Bateman DE, Cleland PG, et al. Intravenous methylprednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiatry. 1985;48:157-159.